Your browser doesn't support javascript.
loading
Rationale and design of the EMPYREAN study.
Motoki, Hirohiko; Masuda, Izuru; Yasuno, Shinji; Oba, Koji; Shoin, Wataru; Usami, Satoru; Saito, Yoshihiko; Waki, Masako; Komatsu, Mitsuhisa; Ueshima, Kenji; Nakagawa, Yasuaki; Son, Cheol; Yonemitsu, Shin; Hiramitsu, Shinya; Konda, Manako; Onishi, Katsuya; Kuwahara, Koichiro.
Afiliación
  • Motoki H; Department of Cardiovascular Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
  • Masuda I; Medical Examination Center, Takeda Hospital, Kyoto, Japan.
  • Yasuno S; Clinical Research Support Center, The Jikei University School of Medicine, Tokyo, Japan.
  • Oba K; Department of Biostatistics, School of Public Health, The University of Tokyo, Tokyo, Japan.
  • Shoin W; Interfaculty Initiative in Information Studies, The University of Tokyo, Tokyo, Japan.
  • Usami S; Department of Cardiovascular Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
  • Saito Y; Department of Internal Medicine, Taigenkai Hospital, Ichinomiya, Japan.
  • Waki M; Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan.
  • Komatsu M; Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
  • Ueshima K; Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
  • Nakagawa Y; Department of EBM Research, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan.
  • Son C; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Yonemitsu S; Division of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Hiramitsu S; Omics Research Center, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Konda M; Department of Diabetes and Endocrinology, Osaka Red Cross Hospital, Osaka, Japan.
  • Onishi K; Hiramitsu Heart Clinic, Nagoya, Japan.
  • Kuwahara K; Department of Preventive Services, Kyoto University School of Public Health, Kyoto, Japan.
ESC Heart Fail ; 7(5): 3134-3141, 2020 10.
Article en En | MEDLINE | ID: mdl-32578353
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: ESC Heart Fail Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: ESC Heart Fail Año: 2020 Tipo del documento: Article País de afiliación: Japón